Skip to main content
SpringerLink
Log in

Drug treatment in stage 1 hypertension cost effective age ≥ 60 regardless of 10-year CVD risk

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Constanti M, et al. Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk. Hypertension : 21 Dec 2020. Available from: URL: https://doi.org/10.1161/HYPERTENSIONAHA.120.14913

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug treatment in stage 1 hypertension cost effective age ≥ 60 regardless of 10-year CVD risk. PharmacoEcon Outcomes News 869, 11 (2021). https://doi.org/10.1007/s40274-021-7378-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7378-8

Search

Navigation